Development by UCLA-led research team works to keep blood sugar at normal levels
UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes.
The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.
Insulin is a hormone naturally produced in the pancreas. It helps the body regulate glucose, which is consumed through food and provides the body with energy.
Diabetes occurs when a person’s body does not naturally produce insulin (Type 1 diabetes), or does not efficiently use the insulin that is produced (Type 2). In either case, a regular dosage of insulin is prescribed to manage the disease, which affects more than 400 million people worldwide.
Generally, people who need to use insulin monitor their blood sugar levels with a glucose meter or continuous glucose monitoring system and then calculate their insulin dose accordingly. In addition, a regular carbohydrate intake is important to keep the blood sugar levels normal. Both of these requirements are necessarily subject to human error, which can have potentially devastating consequences.
An overdose of insulin can cause hypoglycemia, when blood sugar is too low. That could lead to seizures, coma, and in extreme cases, death.
As a safety check, the UCLA-led team has developed a type of “smart” insulin, called i-insulin, that can prevent blood sugar levels from dipping too low.
Inside the body, insulin acts as a “key” to help glucose get into cells from the bloodstream. When insulin attaches to a cell’s surface, it activates a protein inside the cell, called glucose transporter, which then makes its way to the cell’s surface. This molecule then brings the surrounding glucose from the blood into the cell.
The research team added an additional molecule to insulin to create the new smart insulin. This added molecule, called a glucose transporter inhibitor, chemically blocks the glucose transporter molecule that has come to the surface. Its presence doesn’t block all glucose from entering, nor does it permanently block the transporter molecules. Instead, it’s part of a dynamic process that depends on how many inhibitor and glucose molecules are present.
“Our new i-insulin works like a ‘smart’ key,” said the study’s principal investigator Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering. “The insulin lets glucose get into the cell, but the added inhibitor molecule prevents too much from going in when blood sugar is normal. This keeps blood sugar at normal levels and reduces the risk of hypoglycemia.”
“This i-insulin can also rapidly respond to high glucose levels,” added Jinqiang Wang, the study’s co-lead author and a postdoctoral researcher in Gu’s research group. “For example, after a meal, when glucose levels climb, the insulin level in the bloodstream also quickly increases, which helps normalize the glucose level.”
The UCLA-led research team tested the smart insulin on mice with Type 1 diabetes. The i-insulin controlled glucose levels within the normal range for up to 10 hours after a first injection. A second injection three hours later extended the protection from hypoglycemia.
“The next step is to further evaluate the long-term biocompatibility of the modified insulin system in an animal model before determining whether to move to clinical trials,” said co-author Dr. John Buse, a professor and director of the Diabetes Care Center at the University of North Carolina School of Medicine. “The vision, if realized, would be one of the most exciting advances in diabetes care.”
“The new insulin has the potential to be optimized for response times and how long it could last in the body before another dose would be required,” Gu said. “And it could be delivered in other methods, such as a skin patch with tiny needles, or in pills.”
The Latest on: Diabetes
[google_news title=”” keyword=”diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Diabetes
- What Is The Link Between Diabetes And Osteoporosis? See What Experts Sayon November 27, 2023 at 3:27 am
This increased susceptibility is mostly caused by inadequate blood sugar management and diabetes management-related variables.
- Denied long-term disability for diabetes? 3 things you must doon November 27, 2023 at 3:00 am
If your insurer rejects your LTD claim for diabetes, don’t appeal the decision before seeking legal advice, say disability lawyers.
- Ozempic shortage impact on Canadian patients with Type 2 diabeteson November 26, 2023 at 6:19 pm
Some people living with diabetes say they're being forced to switch their medication because of a shortage of Ozempic. The drug is approved for the treatment of Type 2 diabetes, but is also prescribed ...
- 12 Best Diabetes Stocks To Buy Nowon November 26, 2023 at 12:11 pm
In this article, we shall discuss the 12 best diabetes stocks to buy now. To skip our detailed analysis of the global diabetes drugs industry in 2023, go directly and see 5 Best Diabetes Stocks to Buy ...
- Ottawa man calling for limits on off-label prescriptions for diabetes medicationon November 26, 2023 at 8:50 am
An Ottawa man is trying to bring more awareness about the shortage of diabetes drugs that have become popular weight-loss tools to Parliament.
- Take charge of your diabeteson November 26, 2023 at 8:00 am
By visiting your doctor regularly and prioritizing your health, you can take charge of your diabetes. Early recognition and intervention can prevent complications and promote better overall health for ...
- Ask a doctor: Is it possible to reverse my diabetes?on November 26, 2023 at 8:00 am
Unlock the path to Type 2 diabetes reversal—explore hope, challenges, and effective sugar control strategies for a healthier life.
- Nicklaus Children’s Offers the Latest Treatments for Pediatric Diabetes and Endocrinology Care in Locations Throughout South Floridaon November 26, 2023 at 6:00 am
Unlocking a healthier future for young lives! Join Nicklaus Children’s Hospital in its pioneering approach to diabetes care for kids.
- FDA approves new version of Eli Lilly’s diabetes drug for weight losson November 26, 2023 at 6:00 am
FDA greenlights Zepbound, Eli Lilly’s breakthrough weight-loss drug, heralding a new era in obesity treatment.
- Seniors with prediabetes should eat better, get moving, not fret too much about diabeteson November 26, 2023 at 6:00 am
Take a deep dive into the mystery of prediabetes in older adults and find the path to a healthier and more active lifestyle!
via Bing News